Articles dans des revues avec comité de lecture (16)
  1. 13. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Pieters, K., Mineur, P., Le Roy, C., Saint-Georges, S., Varin-Blank, N., Cymbalista, F., Bron, D., & Lagneaux, L. (2012). AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments. Haematologica, 97(4), 608-615. doi:10.3324/haematol.2011.052779
  2. 14. De Bruyn, C., Najar, M., Raicevic, G., Meuleman, N., Pieters, K., Stamatopoulos, B., Delforge, A., Bron, D., & Lagneaux, L. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem cells and development, 20(3), 547-557. doi:10.1089/scd.2010.0260
  3. 15. De Bruyn, C., Najar, M., Raicevic, G., Meuleman, N., Pieters, K., Stamatopoulos, B., Delforge, A., Bron, D., & Lagneaux, L. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from wharton's jelly without enzymatic treatment. Stem cells and development, 20(3), 547-557. doi:10.1089/scd.2010.0260
  4. 16. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Pieters, K., Anthoine, G., Mineur, P., Bron, D., & Lagneaux, L. (2010). A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients. PloS one, 5(9). doi:10.1371/journal.pone.0012780
    5. << Précédent 1 2 Suivant >>